Several other research firms have also weighed in on CURLF. Needham & Company LLC decreased their target price on shares of Curaleaf from $17.00 to $15.00 and set a buy rating on the stock in a report on Friday, March 4th. MKM Partners reiterated a buy rating and issued a $14.00 target price on shares of Curaleaf in a report on Tuesday. Cantor Fitzgerald boosted their target price on shares of Curaleaf from $15.50 to $16.50 and gave the company an overweight rating in a report on Monday, April 25th. Finally, Benchmark started coverage on shares of Curaleaf in a report on Friday, February 25th. They issued a buy rating and a $12.00 target price on the stock. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of Buy and a consensus target price of $18.64.
CURLF stock opened at $5.91 on Tuesday. The firm has a 50-day simple moving average of $6.35 and a 200-day simple moving average of $7.82. Curaleaf has a 52 week low of $5.08 and a 52 week high of $15.47.
About Curaleaf (Get Rating)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements.
- Get a free copy of the StockNews.com research report on Curaleaf (CURLF)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.